NeoGenomics: Q1 Earnings Insights

NeoGenomics NEO reported its Q1 earnings results on Monday, May 8, 2023 at 04:05 PM.

Here's what investors need to know about the announcement.

NeoGenomics beat estimated earnings by 40.0%, reporting an EPS of $-0.09 versus an estimate of $-0.15.

Revenue was up $20.05 million from the same period last year.

Last quarter the company beat on EPS by $0.1 which was followed by a 5.11% drop in the share price the next day.

Here's a look at NeoGenomics's past performance:

Quarter	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022
EPS Estimate	-0.15	-0.16	-0.21	-0.22	-0.23
EPS Actual	-0.09	-0.06	-0.14	-0.16	-0.20
Revenue Estimate	126.39M	129.97M	121.54M	123.37M	116.68M
Revenue Actual	137.22M	138.71M	128.78M	125.07M	117.17M

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

NeoGenomics management provided guidance for FY 2023, expecting earnings between $-0.36 and $-0.3 per share.

To track all earnings releases for NeoGenomics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.